Melissa Johnson
Psychiatric/Mental Health · Waukesha, WINPI 1740797133
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Amgen accounts for 91.8% of it on its own, with 2 other manufacturers making up the rest.
Across 76 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Medline Industries LP$91
- Otsuka America Pharmaceutical, Inc.$23
Across 1 payment — averaging $590.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$590
What the payments were for
- Food & beverage$1,392100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 74 | $1,277 |
| Medline Industries LP | 1 | $91 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$116
How this compares
$1,392 in reported general payments places this provider in the 75th percentile of 384 psychiatric/mental health providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 22 | $84,143 |
| Invega SustennaPaliperidone Palmitate | 19 | $68,976 |
| Divalproex Sodium | 109 | $4,728 |
| Mirtazapine | 81 | $3,503 |
| Risperidone | 133 | $3,066 |
| Olanzapine | 66 | $2,761 |
| Quetiapine Fumarate | 63 | $1,802 |
| Trazodone Hcl | 138 | $1,613 |
| Sertraline Hcl | 124 | $1,592 |
| Haloperidol | 28 | $1,511 |
| Escitalopram Oxalate | 70 | $1,310 |
| Aripiprazole | 15 | $1,092 |
| Valproic AcidValproic Acid (As Sodium Salt) | 20 | $944 |
| Buspirone Hcl | 44 | $761 |
| Oxcarbazepine | 13 | $456 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Waukesha
- Jillian O'GradyWaukesha$7K
- Carolyn DavidsonMilwaukee$46K
- Sherry AleksichMilwaukee$33K
- Bobbi DurstPewaukee$23K
- Ngozi ObioraMilwaukee$19K
- Glenda McConnellGreen Bay$14K
- Debra BenishekGreen Bay$12K
- Shalonda MylesBrown Deer$12K
- Victoria McGinleyMilwaukee$9K
- Janet BurnsBrookfield$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.